Abstract
Major efforts are under way to define reliable biomarkers of Alzheimer's disease. Highly significant increases of hyperphosphorylated tau proteins in cerebrospinal fluid have been recently reported in Alzheimer's disease patients compared to controls by several independent groups, including ours. These findings support the notion that cerebrospinal fluid phosphorylated tau proteins may be very useful biomarkers in the early identification of Alzheimer's disease in patients with mild cognitive impairment.
Original language | English |
---|---|
Pages (from-to) | 27-30 |
Number of pages | 4 |
Journal | Periodicum Biologorum |
Volume | 110 |
Issue number | 1 |
State | Published - Feb 2008 |